Patents
Patents for C07K 19 - Hybrid peptides (29,428)
10/1996
10/02/1996EP0735139A1 Heteropolymeric protein production
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0487621B1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996CN1132527A G-CSF analogue compsn. and its prepn. method
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/25/1996EP0733371A1 Agent for the subcutaneous application of protein C
09/25/1996EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF
09/25/1996EP0511308B1 Chimeric immunoglobulin for cd4 receptors
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/24/1996US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
09/22/1996CA2172217A1 Agent for subcutaneous administration of protein c
09/19/1996WO1996028559A1 Method for the production of cationic peptides
09/19/1996CA2215362A1 Method for the production of cationic peptides
09/18/1996EP0732402A2 Chimeric chains for receptor-associated signal transduction pathways
09/18/1996EP0731806A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
09/12/1996WO1996027612A1 Production in yeasts of stable antibody fragments
09/12/1996WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996021028A3 Soluble heterodimeric t cell receptors and their antibodies
09/12/1996CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/11/1996EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/11/1996EP0730660A1 Chimeric proteins including protease nexin-1 variants
09/11/1996EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
09/11/1996EP0484401B1 Production of vascular endothelial cell growth factor
09/11/1996EP0381719B1 Cellulose binding fusion proteins
09/06/1996WO1996027011A1 A method for making heteromultimeric polypeptides
09/06/1996WO1996026733A1 Codominance-mediated toxins
09/06/1996WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
09/06/1996WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1
09/04/1996EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors
09/04/1996EP0420911B1 Gene therapy using gene fusions for genetic or acquired disorders
09/04/1996CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use
08/1996
08/29/1996WO1996026281A1 Chimeric adenoviral fiber protein and methods of using same
08/29/1996WO1996026277A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
08/29/1996WO1996026274A1 Antagonists of interleukin-15
08/29/1996WO1996026265A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras
08/29/1996WO1996025953A1 Redirection of cellular immunity by receptor chimeras
08/29/1996CA2211995A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
08/28/1996EP0728191A1 A secretion sequence for the production of a heterologous protein in yeast
08/28/1996CN1129737A Modified protein for gene transfer and process for producing the same
08/27/1996US5550027 Screening blood donors for chagas disease
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996015149A3 Methods and compositions for screening for presynaptic calcium channel blockers
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/21/1996EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/20/1996US5547853 CD2-binding domain of lymphocyte function associated antigen 3
08/20/1996US5547670 Polypeptides
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS
08/15/1996WO1996024673A1 Mucosal vascular addressins and uses thereof
08/15/1996WO1996012019A3 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
08/15/1996CA2212054A1 Gnrh-leukotoxin chimeras
08/14/1996EP0725793A1 Protease-derivatized cvf
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996EP0456790B1 Antibody variable domain conjugates
08/13/1996US5545718 Synthetic peptides of the conjugate of ubiquitine and H2A histone
08/13/1996CA1338518C Antibody heteroconjugates for the killing of hiv-infected cells
08/08/1996WO1996023888A1 NOVEL c-MPL LIGANDS
08/08/1996WO1996023816A1 Radiolabelled proteins
08/08/1996CA2212006A1 Novel c-mpl ligands
08/01/1996WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof
07/1996
07/31/1996EP0723555A1 Chimeric proteins which block complement activation
07/30/1996US5541110 Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
07/30/1996US5540926 Gp39 protein
07/30/1996CA1338501C Method of detecting antibody against htlv-iii
07/25/1996WO1996022377A1 Activation of t-cells by modified, antigenic immunoglobulins
07/25/1996CA2210997A1 Activation of t-cells by modified, antigenic immunoglobulins
07/25/1996CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
07/24/1996EP0723015A1 Novel modified PF4 compositions and methods of use
07/24/1996EP0722495A1 A method for displaying proteins
07/24/1996EP0722461A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
07/24/1996EP0555336B1 Homobifunctional agents for coupling enzymes and the like to antibodies and the like
07/23/1996US5539083 Peptide nucleic acid combinatorial libraries and improved methods of synthesis
07/23/1996US5538866 Immunoassay; medical diagnosis
07/23/1996US5538862 Heat-inducible N-degron module
07/18/1996WO1996021458A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases
07/18/1996CA2210088A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases
07/17/1996EP0721983A1 Methods of producing biologically active peptide dimers
07/17/1996EP0721470A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
07/17/1996EP0721469A1 Anti-gp39 antibodies and uses therefor
07/17/1996EP0721346A1 Methods for inducing antigen-specific t cell tolerance
07/11/1996WO1996021028A2 Soluble heterodimeric t cell receptors and their antibodies
07/11/1996WO1996021012A1 Methods for producing immunoglobulins containing protection proteins in plants and their use
07/11/1996WO1996020951A1 Chimeric dna-binding proteins
07/11/1996CA2209183A1 Chimeric dna-binding proteins
07/10/1996EP0720650A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
07/10/1996EP0720486A1 Peripheralization of hematopoietic stem cells
07/10/1996EP0370090B1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens
07/10/1996CN1126494A Method for recombinant production of biologically active polypeptides
07/09/1996US5534257 Genetic engineering; insertion of foreign peptide epitope; vaccines
07/09/1996US5534254 Biosynthetic binding proteins for immuno-targeting
07/09/1996US5534223 Immunoenzymological assay for proteins using alkaline phosphatase joined to polypeptides and interacting with antigens or antibodies